Abstract:In recent years, great interest has been paid to the development of compounds with high selectivity for central dopamine (DA) D3 receptors, an interesting therapeutic target in the treatment of different neurological disorders. In the present work, based on a dataset of 110 collected benzazepine (BAZ) DA D3 antagonists with diverse kinds of structures, a variety of in silico modeling approaches, including comparative molecular field analysis (CoMFA), comparative similarity indices analysis (CoMSIA), homology modeling, molecular docking and molecular dynamics (MD) were carried out to reveal the requisite 3D structural features for activity. Our results show that both the receptor-based (Q2 = 0.603, R2ncv = 0.829, R2pre = 0.690, SEE = 0.316, SEP = 0.406) and ligand-based 3D-QSAR models (Q2 = 0.506, R2ncv =0.838, R2pre = 0.794, SEE = 0.316, SEP = 0.296) are reliable with proper predictive capacity. In addition, a combined analysis between the CoMFA, CoMSIA contour maps and MD results with a homology DA receptor model shows that: (1) ring-A, position-2 and R3 substituent in ring-D are crucial in the design of antagonists with higher activity; (2) more bulky R1 substituents (at position-2 of ring-A) of antagonists may well fit in the binding pocket; (3) hydrophobicity represented by MlogP is important for building satisfactory QSAR models; (4) key amino acids of the binding pocket are CYS101, ILE105, LEU106, VAL151, PHE175, PHE184, PRO254 and ALA251. To our best knowledge, this work is the first report on 3D-QSAR modeling of the new fused BAZs as DA D3 antagonists. These results might provide information for a better understanding of the mechanism of antagonism and thus be helpful in designing new potent DA D3 antagonists.

CoMFA, CoMSIA, and Molecular Hologram QSAR Studies of Novel Neuronal Nachrs Ligands-Open Ring Analogues of 3-Pyridyl Ether

QSAR Study of a Large Set of 3-Pyridyl Ethers As Ligands of the Α4β2 Nicotinic Acetylcholine Receptor

Molecular hologram QSAR study of 3-pyridyl ether analogues

Design, Synthesis, And Sar Studies Of Heteroarylpyrimidines And Heteroaryltriazines As Cb2r Ligands

Comfa and Comsia Studies of Nachrs Ligands: Epibatidine Analogues

Structure activity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) analogues as potent opioid receptor ligands: preliminary results on the role of electronic characteristics for affinity and function.

3 D-Qsar Analysis of Agonists of Nachrs: Epibatidine Analogues

3D-QSAR Studies on AChE Inhibitory Activities of 2-Phenoxy-indan-1-one Derivatives

Three-dimensional quantitative structure–activity relationship study for analogues of TQXs using CoMFA and CoMSIA

QSAR Studies of Novel Pyridylamine Ligands for the Nicotinic Acetylcholine Receptor

Studies of New Fused Benzazepine As Selective Dopamine D3 Receptor Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics

CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors

Binding Mode Analyses of NAP Derivatives As Mu Opioid Receptor Selective Ligands Through Docking Studies and Molecular Dynamics Simulation

Studies of Phenylethynyl-pyrrolo[1,2-a]pyrazine as mGluR5 Antagonists Using 3D-QSAR Method

3D-QSAR Analysis on N-Phenylacetanoyl-L-Homoserine Lactones As Inhibitors of Bacterial Quorum Sensing Via CoMFA Approach

3D-QSAR and Molecular Docking Studies of Novel GPR52 Agonists

Studies on Three-Dimensional Qsar of Muscarinic Receptor Agonists

Qsar of Pyrazole Oxadiazole Derivatives As S1p1 Agonists Studied by Comfa, Comsia and Docking

Hqsar and Topomer Comfa for Predicting Melanocortin-4 Receptor Binding Affinities of Trans-4-(4-Chlorophenyl) Pyrrolidine-3-Carboxamides

Novel Pyridyl Ring C5 Substituted Analogues Of 3-(1-Methyl-2(S)- Pyrrolidinylmethoxy)Pyridine (A-84543) As Highly Selective Agents For Neuronal Nicotinic Acetylcholine Receptor(Nachr)

Studies of H4R Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics